MYCIO Wealth Partners’s Aevi Genomic Medicine Inc GNMX Stock Holding History

MYCIO Wealth Partners’s Portfolio GNMX Stock Details GNMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,000	Closed	-$1K	–	467
2019 Q4	$1K	Hold	10,000	–	–	﹤0.01%	467
2019 Q3	$2K	Hold	10,000	–	–	﹤0.01%	447
2019 Q2	$2K	Hold	10,000	–	–	﹤0.01%	405
2019 Q1	$2K	Hold	10,000	–	–	﹤0.01%	295
2018 Q4	$7K	Hold	10,000	–	–	﹤0.01%	289
2018 Q3	$12K	Hold	10,000	–	–	﹤0.01%	286
2018 Q2	$11K	Hold	10,000	–	–	﹤0.01%	277
2018 Q1	$20K	Buy	+10,000	New	+$18.8K	﹤0.01%	254

MYCIO Wealth Partners's GNMX Position: Q1 2020 in Review

MYCIO Wealth Partners sold out of Aevi Genomic Medicine Inc (GNMX) in Q1 2020, closing a stake of 10,000 shares — an estimated $1K sold.

MYCIO Wealth Partners first reported a position in GNMX in Q1 2018 and held it in 8 quarters. The position peaked at $20K in Q1 2018. 2 funds tracked by Wall St. Rank hold GNMX as of Q1 2020.

MYCIO Wealth Partners reported no remaining Aevi Genomic Medicine Inc position as of Q1 2020 after selling out during the quarter.
MYCIO Wealth Partners sold 10,000 Aevi Genomic Medicine Inc shares in Q1 2020, an estimated $1K.
MYCIO Wealth Partners first reported a position in Aevi Genomic Medicine Inc in Q1 2018 and held it in 8 quarters.
MYCIO Wealth Partners's Aevi Genomic Medicine Inc position peaked at $20K in Q1 2018.
2 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q1 2020.

Based on MYCIO Wealth Partners's 13F filing for Q1 2020, filed 14 May 2020.